Status:
UNKNOWN
Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study
Lead Sponsor:
University College, London
Collaborating Sponsors:
The University of Hong Kong
Conditions:
Dementia
Dementia, Vascular
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Due to COVID-19, the routine treatment for dementia, Cognitive Stimulation Therapy (CST), is currently suspended in multiple countries. Access to treatment is, therefore, paramount. The investigators ...
Detailed Description
Dementia, a global epidemic, affects 50 million individuals worldwide. Cognitive Stimulation Therapy (CST) is the only non-pharmacological therapy recommended by the UK government to improve cognition...
Eligibility Criteria
Inclusion
- Diagnosis of dementia, according to the DSM-IV
- MoCA - BLIND ≥ 2
- Age ≥ 18
- Ability to communicate in English
- Ability to complete outcome measures
- Capacity to consent
- Consent to video-conferencing
- Access to video-conferencing
Exclusion
- 1\) Illness and disability that affects participation (as deemed by researcher)
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2025
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04828434
Start Date
April 1 2021
End Date
September 1 2025
Last Update
March 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCL
London, United Kingdom, WC1E 6BT